GlassScriptPhysician profile
Randall K Minion
NPI 1003887431
$1,963.20
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $163.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $237.80 | 2019-2020 | |
| Astellas Pharma US INC | $214.90 | 2019 | |
| Glaxosmithkline, LLC. | $214.83 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $209.56 | 2019-2020 | |
| Amgen INC. | $179.44 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.99 | 2019 | |
| Allergan, INC. | $124.23 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $118.41 | 2019 | |
| Lilly USA, LLC | $114.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $80.08 | 2019-2020 | |
| Novo Nordisk INC | $71.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $69.31 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $45.12 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.82 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.30 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $27.71 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.84 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.58 | 2019 | |
| Ironwood Pharmaceuticals, INC | $12.39 | 2019 | |
| Csl Behring | $11.69 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Minion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.